Navigation Links
Nplate(R) Approved in the European Union for the Treatment of Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
Date:2/6/2009

ranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new indication for an existing product will be successful and become a commercial product. Further, preclinical results do not guarantee safe and effective performance of product candidates in humans. The complexity of the human body cannot be perfectly, or sometimes, even adequately modelled by computer or cell culture systems or animal models. The length of time that it takes for us to complete clinical trials and obtain regulatory approval for product marketing has in the past varied and we expect similar variability in the future. We develop product candidates internally and through licensing collaborations, partnerships and joint ventures. Product candidates that are derived from relationships may be subject to disputes between the parties or may prove to be not as effective or as safe as we may have believed at the time of entering into such relationship. Also, we or others could identify safety, side effects or manufacturing problems with our products after they are on the market. Our business may be impacted by government investigations, litigation and products liability claims. We depend on third parties for a significant portion of our manufacturing capacity for the supply of certain of our current and future products and limits on supply may constrain sales of certain of our current products and product candidate development.

In addition, sales of our products are affected by the reimbursement policies imposed by third-party payors, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline developments and domestic and international trends toward managed care and healthcare cost containment as well as U.S. legislation affecting pharmaceutical pricing and reimbursement. Government and others' regulations
'/>"/>

SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
2. Norditropin(R) Approved for Treatment of Children with Short Stature Associated with Turner Syndrome
3. Norditropin(R) Approved for Treatment of Children with Short Stature Associated with Turner Syndrome
4. Nexavar First FDA-Approved Drug Therapy for Liver Cancer
5. Newly Approved HIV Drug Shows Great Promise
6. Independent Physician Surveys Show if Approved, MF101 Could Become First-Line Treatment for Menopause Symptoms
7. Treximet(TM) (Sumatriptan and Naproxen Sodium) Tablets Approved by FDA for Acute Treatment of Migraine
8. Divigel(R) (estradiol gel) 0.1 Percent Offers Lowest Approved Dose of Estradiol for Treatment of Moderate to Severe Hot Flashes Associated with Menopause
9. FDA Broadens US Indication for Once-Yearly Reclast(R) as Only Osteoporosis Treatment Approved for Prevention of Fractures After a Hip Fracture
10. BRIDION(R) (sugammadex) Injection - First and Only Selective Relaxant Binding Agent - Approved in European Union
11. Pediatric Heart Transplants at Montefiore Approved by NY State Department of Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... , July 7, 2015  Dedicated to promoting ... Leonard,s® Healthcare Corp. took the purple pledge in ... is Alzheimer,s & Brain-Awareness Month, a time to shine ... the world and all the people in our community ... those struggling with the disease, and helps mobilize friends, ...
(Date:7/7/2015)... BANGALORE , July 7, 2015 /PRNewswire/ ... provider of innovative clinical trial data management solutions, has ... Reports) recent publication named " EDC and eCOA / ... ISR Reports is one of the leading providers of ... report evaluated 22 EDC and eCOA / ePRO tools ...
(Date:7/7/2015)... July 7, 2015   Bionik Laboratories Corp. ... company with a core focus in robotic exoskeleton ... the "Company"), announced today that it has completed ... units consisting of its common stock and warrants ... in a private placement transaction.  This equity financing ...
Breaking Medicine Technology:Purple for a Purpose: Supporting Alzheimer's & Brain-Awareness Month 2Acceliant Ranked Highest in 'Overall Satisfaction' Amongst EDC Providers in ISR Reports' Recent Research 2Acceliant Ranked Highest in 'Overall Satisfaction' Amongst EDC Providers in ISR Reports' Recent Research 3Bionik Laboratories Completes US$13.1 Million Private Placement 2Bionik Laboratories Completes US$13.1 Million Private Placement 3
... , , , ROCKVILLE, Md., ... of getting breast cancer, but each drug carries distinct potential harms ... for Healthcare Research and Quality. , , Drugs ... women with a family history of breast cancer or other risk ...
... , HONG KONG, Sept. 15 ... pro-healing stent, OrbusNeich,s Genous Bio-engineered R stent, and preclinical data ... week at the Transcatheter Cardiovascular Therapeutics symposium, TCT 2009, in ... M.D., Ph.D., of the Academic Medical Center in Amsterdam will ...
Cached Medicine Technology:Medications Effective in Reducing Risk of Breast Cancer But Increase Risk of Adverse Effects, New Report Says 2Medications Effective in Reducing Risk of Breast Cancer But Increase Risk of Adverse Effects, New Report Says 3Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2009 2Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2009 3
(Date:7/7/2015)... (PRWEB) , ... July 07, ... ... Refining convenience stores throughout the Southwest, including Giant, Mustang, Sun Dial and ... mobile program, surpassing their original 2015 fundraising goal by nearly $100,000, to ...
(Date:7/7/2015)... ... July 07, 2015 , ... A ... facial rejuvenation that have emerged about Hillary Clinton. Two plastic surgeons consulted by ... more youthful than she has in some time and speculate that she might ...
(Date:7/7/2015)... ... ... Quadrino Law Group is pleased to announce the relocation of the firm's headquarters to ... is a state of the art building, located with easy access to New York ... said, "We are pleased to service our clients from such a premier location and ...
(Date:7/7/2015)... , ... July 07, 2015 , ... Safe Catch is ... single fish for mercury. Albertsons, Gelson’s Markets, New Leaf Community Markets, Sprouts Farmers Market ... , “We developed the technology to test every fish for mercury,” said Safe Catch ...
(Date:7/7/2015)... ... July 07, 2015 , ... Parents and guardians of teenagers or young ... an open-ended holistic treatment center for drug and alcohol abuse located in Southwest Michigan. ... Research has shown a significant increase in the “club drug” use among high school ...
Breaking Medicine News(10 mins):Health News:Western Refining Raises $524,286 to Help Send Kids with Neuromuscular Disease to MDA Summer Camp 2Health News:Western Refining Raises $524,286 to Help Send Kids with Neuromuscular Disease to MDA Summer Camp 3Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 2Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 3Health News:Safe Catch Launches Tuna with Lowest Mercury Limit of Any Brand 2Health News:A Forever Recovery Releases New Information on “Club Drugs” and Tips for Parents of Teens and Young Adults 2
... Britons are packed with dust mites, fungus and skin scales.// ... to contain up to 20,000 live house dust mites in addition ... unwashed duvet revealed over an ounce and a half of debris ... addition it was found that more than four in ten people ...
... in Melbourne Australia have performed the first incompatible blood ... Royal Melbourne hospital have performed a kidney transplant despite ... was explained that Davorin Gelemanovic, 24, who is of ... from his father, who has type A blood. Mr ...
... Tata group, the Essar group and the Jindal group ... that would ensure medicare for people leaving Below Poverty ... first public-private partnership, the Sarva Swasthya Mission trust is ... major corporate groups, an official release said here today ...
... well as a good balanced diet can avert strokes in ... 1993 with over 37,600 women as participants//. ,All ... rated on a "health index score." The scores ranged from ... the woman. ,The women were followed for a ...
... of India have accorded sanction to the Karnataka government to ... from this academic year, the state assembly was informed today. ... in Belgaum and Mandya, Medical Education Minister V S Acharya ... MCI has approved an intake of 100 students in each ...
... The death toll in Dooars and Terai region of North ... and a half months till yesterday. // ,Chief ... malaria deaths were reported in Dooars region of Jalpaiguri district, ... days in the area., ,In the Terai region at ...
Cached Medicine News:Health News:Dust mites use Duvets as their Haven 2
... Re-insulation capabilities that extend the life of ... bring them back to life, expertise you ... trademark. Our maintenance capabilities always help you ... Economical and fast, not only do we ...
... know their instruments will consistently perform correctly. ... Instrument for instrument repair than any other ... carbide inserts and all repairs are micro-inspected ... enjoy 24-hour turnaround from our repair center ...
... fiber and video scopes including bronchoscopes, cystoscopes, ... OR and endoscopy. Quality is of utmost ... the standards of the OEM. We back ... defects in materials and workmanship. Quotes are ...
Inquire...
Medicine Products: